已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

S9 Adverse Events and Device Failures Associated With Pancreatic Stents: A Comprehensive Analysis Using the FDA's MAUDE Database

医学 不利影响 穿孔 胰腺炎 不良事件报告系统 数据库 食品药品监督管理局 内镜治疗 胰管 急诊医学 内科学 外科 内窥镜检查 医疗急救 材料科学 冶金 冲孔 计算机科学
作者
Fouad Jaber,Saqr Alsakarneh,Mohammad Jaber,Khalid K. Ahmed,Azizullah Beran,Khaled Elfert,Ahmed Salih,Manasik Abdu,Yazan Abboud,Zubair Khan,Mohamed Ismail,Joseph Sleiman,Mohamed Abdallah,Ala Abdel-Jalil,Mohammad Bilal
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:118 (10S): S8-S9
标识
DOI:10.14309/01.ajg.0000949676.28499.48
摘要

Introduction: Pancreatic duct stents (PDS) are widely used for the prevention of post-ERCP pancreatitis and for pancreatic endotherapy in chronic pancreatitis patients. Several commercially available PDS are commonly utilized. However, there is a paucity of data regarding the adverse events associated with PDS placement. This study aims to investigate the reported adverse events and device failures related to PDS, utilizing the Manufacturer and User Facility Device Experience (MAUDE) database maintained by the U.S. Food and Drug Administration (FDA). Methods: Post-marketing surveillance data from January 2010 to May 2023 were extracted from the FDA's MAUDE database to analyze the outcomes associated with PDS. Reports pertaining to the use of commonly used PDS including Advanix (Boston Scientfic), Geenan (Cook endoscopy), and Zimmon (Cook endoscopy) pancreatic stents were analyzed. The primary outcomes of interest were device problems and patient-related adverse events. Statistical analysis was performed using Microsoft Excel 2010, with calculation of pooled numbers and percentages for each device and patient adverse event. Results: During the study period, a total of 540 device problems and 582 patient-related adverse events were identified. Device failures (Figure 1) were primarily attributed to device or usage problems (n=145, 26.9%), followed by off-label use (n=144, 26.7%), and material or component issues (n=120, 22.2%). The most common patient-related adverse events were reported as having no harm or consequences to patients (n=400, 68.7%). Other reported patient adverse events included inflammation (n=24, 4.1%), perforation (n=16, 2.7%), foreign body presence (n=14, 2.4%), and pancreatitis (n=10, 1.7%). The highest number of device failures was associated with Zimmon pancreatic stents (n=217, 40.2%), followed by Geenen pancreatic stents (n=216, 40%) and Advanix (n=107, 19.8%). Device or usage problems were most frequently reported with the use of Zimmon stents (n=79, 36.4%), followed by Geenen stents (n=60, 27.8%). Conclusion: Most reported device-related issues were attributed to device or usage problems, and the majority of device failures did not result in harm to patients. Information from this study can be used in improving pancreatic duct stent designs for future iterations.Figure 1.: A) Device Failures associated with pancreatic stents. B) Patient-related adverse Events associated with pancreatic stents. Device or Use Problems (Adverse Event Without Identified Device or Use Problem, no apparent adverse events, Use of Device Problem, Improper or Incorrect Procedure or Method, Device Operates Differently Than Expected), Activation, Positioning or Separation Problem (Activation Failure, Activation, Difficult or Delayed Positioning, Positioning or Separation Problem, Positioning Failure, Positioning Problem), Material or Component Problems (Break, Material Deformation, Material Integrity Problem, Material Puncture/Hole, defective device, component failing, fracture), Device Markings or Packaging Problems (Device Markings/Labelling Problem, Device Packaging), Difficulties with Device (Difficult to Advance, Difficult to Remove, Device Difficult to Setup or Prepare, failure to advance), Migration (Migration or Expulsion of Device, Migration, Detachment of Device or Device Component), Sterilization (Problem with sterilization, Contamination /Decontamination Problem), Others (Entrapment of Device, Retraction Problem; Stretched, off label use, biocompatibility, fluid/blood leakage, appropriate code not available, insufficient information, obstruction of flow, leak/splash) Pain related (Abdominal pain/pain/implant pain), Bleeding-related (Bleeding/hemorrhage, blood).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lyl发布了新的文献求助10
刚刚
xuemin发布了新的文献求助10
1秒前
Son4904完成签到,获得积分10
1秒前
2秒前
2秒前
zzzyoho完成签到,获得积分10
2秒前
动听衬衫完成签到 ,获得积分10
2秒前
顺利毕业完成签到 ,获得积分10
2秒前
强健的梦秋完成签到,获得积分10
5秒前
6秒前
tammy发布了新的文献求助30
6秒前
根号五发布了新的文献求助10
7秒前
8秒前
兜里没糖了完成签到 ,获得积分0
9秒前
隐形曼青的应助被Echo采纳,获得10
9秒前
古月完成签到,获得积分10
10秒前
阿宁完成签到,获得积分10
10秒前
orixero的应助被杨yy采纳,获得10
11秒前
碧蓝问玉完成签到,获得积分10
12秒前
14秒前
你好完成签到,获得积分10
14秒前
14秒前
孤独剑完成签到 ,获得积分10
16秒前
Jackson发布了新的文献求助10
16秒前
希望天下0贩的0的应助被车车采纳,获得10
16秒前
19秒前
20秒前
熊猫爱豆浆完成签到,获得积分10
21秒前
可爱的函函的应助被海明威采纳,获得10
21秒前
火星上的芳芳完成签到,获得积分10
22秒前
wway完成签到 ,获得积分10
23秒前
25秒前
变成糕手完成签到 ,获得积分10
25秒前
26秒前
青山完成签到 ,获得积分20
27秒前
JohnYoung完成签到,获得积分10
28秒前
英姑的应助被zzzyoho采纳,获得10
29秒前
烟花的应助被土土土采纳,获得10
29秒前
灯火阑珊完成签到 ,获得积分10
30秒前
谦让万天完成签到 ,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165680
求助须知:如何正确求助?哪些是违规求助? 9559223
关于积分的说明 21749486
捐赠科研通 7756436
什么是DOI,文献DOI怎么找? 3429005
关于科研通互助平台的介绍 2553275
邀请新用户注册赠送积分活动 2473568